NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
ID: 344643Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344643

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-065.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for the Resource-Related Research Projects (R24) grant, aimed at supporting non-clinical, investigator-initiated projects that enhance existing high-priority research efforts in the biomedical field. This funding opportunity seeks to develop essential resources, data, tools, or services that benefit the broader scientific community while ensuring that they do not duplicate existing resources. The initiative is crucial for advancing research on infectious, immunologic, and allergic diseases, with the expectation of awarding only 1-2 grants per year, each with a project period of up to five years. Interested applicants must comply with new NIH data management policies and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The application deadline is January 7, 2026.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-065-Full-Announcement.html
    PAR-23-065.html
    The National Institute of Allergy and Infectious Diseases (NIAID) invites applications for the Resource-Related Research Projects (R24) grant, specifically for non-clinical, investigator-initiated projects that enhance existing high-priority research efforts. This funding opportunity aims to develop essential resources, data, tools, or services benefiting the broader biomedical community while ensuring they do not duplicate existing resources. Applications are encouraged from diverse eligible organizations, including higher education institutions and non-profits. The funding is contingent upon available appropriations, with expectations of only 1-2 awards per year. The project period can last up to five years, and while budget requests are not capped, they should reflect actual project needs. Notably, compliance with application standards is strictly enforced, and potential applicants should engage with the scientific/research contacts at NIAID prior to submission. Additionally, all applicants must adhere to new NIH data management policies effective from January 25, 2023. Ultimately, this funding initiative reflects NIAID’s mission to advance research on infectious, immunologic, and allergic diseases, supporting the development of resources crucial for ongoing and future scientific inquiries.
    Similar Opportunities
    Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Resource-Related Research Projects for Development of Animal Models and Related Materials," aimed at advancing research that develops and enhances animal models relevant to human diseases. The initiative seeks applications that demonstrate the need for and potential impact of broadly applicable resources across multiple NIH Institutes and Centers, emphasizing projects that address diseases affecting multiple body systems rather than those focused on specific diseases or singular NIH interests. Eligible applicants include higher education institutions, nonprofit organizations, and government agencies, with funding available up to $5 million per year. The application deadline is set for January 25, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is inviting applications for the Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) grant. This funding opportunity aims to support multi-project research initiatives that focus on infectious, immunologic, and allergic diseases, requiring each application to include at least two synergistic research projects and an administrative core, all centered around a common theme. The initiative is crucial for advancing research in areas such as the biology and pathogenesis of infectious microbes, immune system mechanisms, and the development of vaccines and therapeutics. Interested applicants must submit their proposals electronically via Grants.gov by September 7, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The funding amount is not limited but should reflect the actual needs of the proposed projects.
    Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early-stage Biomedical Data Repositories and Knowledgebases," aimed at supporting the development of new or significantly modified data repositories and knowledgebases that enhance biomedical research. This initiative encourages applications from a diverse range of eligible organizations, including higher education institutions and non-profits, with a funding cap of $350,000 per year for a maximum project duration of four years. The importance of this funding lies in its potential to align with FAIR data principles, thereby improving the ecosystem for biomedical research. Interested applicants should note that the application period opens on September 30, 2023, with a Notice of Award expected by early 2024; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed), aimed at supporting investigator-initiated resources that enhance biomedical, behavioral, and social sciences research related to alcohol. This grant mechanism focuses on providing essential data, materials, and services to the broader alcohol research community, rather than supporting hypothesis-driven research, which should be submitted through other mechanisms. The NIH seeks to create high-quality resources that do not duplicate existing offerings, emphasizing the importance of diversity in research participation and encouraging applications from organizations serving underrepresented groups. Applications are due by January 25, 2024, and the project periods can last up to five years, with no cost-sharing or matching requirements. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Genomic Community Resources (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-124) aimed at supporting the development of genomic community resources through cooperative agreements. This initiative seeks to enhance genomic research by funding projects that demonstrate broad applicability and significant value, focusing on the creation of genomic informatics tools, biological material collections, and community engagement efforts. The funded projects will play a crucial role in advancing both basic and clinical genomics research, with awards potentially lasting up to five years. Interested applicants, including a diverse range of organizations such as higher education institutions and nonprofits, must submit their applications by January 25, 2026, and can find further details and submission guidelines at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)" aimed at supporting research on infectious diseases in resource-constrained countries. This initiative encourages applications from organizations based in low- and lower-middle-income economies, as classified by the World Bank, and seeks innovative proposals addressing diseases such as HIV/AIDS, tuberculosis, and malaria, with a focus on enhancing local scientific capacity. The total funding available for fiscal year 2024 is approximately $1,360,000, with individual project budgets capped at $125,000 per year for a maximum of five years. Interested applicants can find more information and submission guidelines at the NIH website, with applications accepted until August 1, 2025.
    NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), has announced a funding opportunity for the Clinical Trial Planning Grant (R34), aimed at supporting the planning and preparation necessary for investigator-initiated clinical trials. This grant encourages applications that focus on high-priority research aligned with NIAID's mission, providing funding of up to $150,000 for activities such as protocol development, study team establishment, and regulatory approvals. The opportunity is open to a diverse range of eligible applicants, including educational institutions, nonprofits, and governmental entities, with applications evaluated based on significance, innovation, and the research environment. Interested applicants should note that the application deadline is May 13, 2026, and can find more information at the provided NIH grants link or by contacting NIH Grants Information at grantsinfo@nih.gov.
    Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)" aimed at exploring the role of inflammasomes in the context of HIV infection and substance use disorders. This R21 exploratory grant encourages research into the mechanisms of inflammasome activation and their association with neurocognitive disorders in individuals affected by HIV and substance use, with a focus on identifying molecular markers and potential therapeutic innovations. The total funding available is up to $2 million over two years, with applications opening on February 13, 2024, and a submission deadline of March 13, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Targeting Inflammasomes in HIV and Substance Use" (RFA-DA-25-069). This initiative aims to support research that elucidates the mechanisms of inflammasome activation related to neurocognitive disorders in individuals affected by HIV and substance use disorders (SUDs), focusing on identifying molecular markers and understanding the inflammatory responses triggered by these conditions. The program is significant for developing new therapeutic tools that could enhance clinical outcomes for affected populations. Up to four grants, totaling $2 million, will be awarded, with applications due by March 14, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for detailed application instructions.
    Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases" through a cooperative agreement mechanism. The initiative aims to support established biomedical data resources that have demonstrated impact and potential for continued benefit to the NIH mission, emphasizing adherence to the FAIR Data Principles (Findable, Accessible, Interoperable, and Reusable). This funding is crucial for maintaining high-quality data resources that bolster biomedical research and ensure effective data management practices. Interested applicants, including various educational institutions and organizations, must submit their proposals by January 25, 2026, and can seek further information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-237.html.